Bernard Massie, Ph.D., graduated in microbiology and immunology from the University of Montreal in 1982 and completed a three-year postdoctoral fellowship at McGill University studying DNA tumor viruses. He worked at the National Research Council of Canada (NRC) from 1985 to 2019 as a biotechnology researcher and held various management positions, including the position of Acting Director General of the Therapeutics in Human Health Center from 2016 to 2019. He has devoted a significant part of his career to the development of integrated bioprocesses for the industrial production of therapeutic antibodies and adenovirus vaccines. He was also an associate professor in the department of microbiology and immunology at the University of Montreal from 1998 to 2019. He is currently an independent consultant in biotechnology.